Louisiana Court Challenges FDA Mifepristone Guidance
The Food and Drug Administration (FDA) issued guidance ending the requirement for in-person dispensing of the drug Mifepristone. This guidance allows the medication to be mailed or picked up at pharmacies.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
ABC NewsRadio AU
“In that guidance from the FDA, they ended the in-person dispensing requirement for the drug, which allowed it to be mailed and picked up in pharmacies, etc. So Louisiana challenged that.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade